• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza A/H1N1 Vaccination Response is Inadequate in Down Syndrome Children When the Latest Cut-Off Values Are Used

tetano

Editor, Senior Moderator
Pediatr Infect Dis J. 2012 Sep 14. [Epub ahead of print]
Influenza A/H1N1 Vaccination Response is Inadequate in Down Syndrome Children When the Latest Cut-Off Values Are Used.
Kusters MA, Bok VL, Bolz W, Huijskens E, Peeters M, de Vries E.
Source

1Dept Pediatrics, Jeroen Bosch Hospital, [Combining Grave Accent]s-Hertogenbosch 2Dept Pediatrics, M?xima Medical Centre, Veldhoven 3Dept Pediatrics, Elkerliek Hospital, Helmond 4Medical Microbiology and Immunology Laboratory, St. Elisabeth Hospital, Tilburg, The Netherlands.
Abstract

We determined the response of 48 Down syndrome (DS) children to 2 doses of influenza A/H1N1 vaccination. 92% reached the previously defined protective level (HI titer ≥1:40), but only 27% reached the level of ≥1:110 which was recently described to predict the conventional 50% clinical protection rate in children. Further studies, and potentially adaptations of the schedule, are needed.

PMID:
22986705
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22986705
 
Back
Top Bottom